卢宾获得FDA的暂定批准,用于一般性Sugammadex注射剂. Lupin receives tentative FDA approval for generic Sugammadex Injection.

制造通用药物公司Lupin已经获得美国FDA的暂时批准, 用于其Sugammadex注射剂版本, 这是一种用于在手术期间逆转肌肉松剂的药物. Generic drugmaker Lupin has received tentative U.S. FDA approval for its version of Sugammadex Injection, a drug used to reverse muscle relaxants during surgery. 批准涵盖两种强度,与默克品牌药物Bridion具有生物等价性. The approval covers two strengths and is bioequivalent to Merck's branded drug Bridion. 这一举措可以增加可负担的药物供应, 尽管最终批准可能取决于解决法律问题. This move could increase access to affordable medication, though final approval may depend on resolving legal issues.